Making flu vaccines used to be a money-losing business. But that all changed with a flu pandemic on the other side of the world. Inoculating the global population against a growing list of illnesses has since spawned a $24-billion market for a few pharmaceutical companies.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment